Natixis Advisors, LLC’s Thermo Fisher Scientific Inc Position
Does Natixis Advisors, LLC own Thermo Fisher Scientific Inc (TMO)? Yes — 550.2K shares worth $270M (+0.38% of its 13F portfolio) as of Q1 2026, down from 588.8K shares the prior filed quarter.
Position Value
$270M
Q1 2026
Shares
550.2K
% of Portfolio
+0.38%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 550.2K | $270M | +0.38% |
| Q4 2025 | 588.8K | $341M | +0.48% |
| Q3 2025 | 482.4K | $234M | +0.34% |
| Q2 2025 | 406.4K | $165M | +0.26% |
| Q1 2025 | 497.3K | $247M | +0.46% |
| Q4 2024 | 428.9K | $223M | +0.42% |
| Q3 2024 | 502.1K | $311M | +0.61% |
| Q2 2024 | 417.4K | $231M | +0.50% |
| Q1 2024 | 376.4K | $219M | +0.50% |
| Q4 2023 | 333.1K | $177M | +0.47% |
| Q3 2023 | 328.9K | $166M | +0.51% |
| Q2 2023 | 269.2K | $140M | +0.43% |
| Q1 2023 | 278.4K | $160M | +0.55% |
| Q4 2022 | 251.2K | $138M | +0.52% |
| Q3 2022 | 220.5K | $112M | +0.47% |
| Q2 2022 | 194.9K | $106M | +0.47% |
| Q1 2022 | 187.7K | $111M | +0.42% |
| Q4 2021 | 254.0K | $169M | +0.65% |
| Q3 2021 | 250.6K | $143M | +0.59% |
| Q2 2021 | 244.5K | $123M | +0.58% |
| Q1 2021 | 208.0K | $95M | +0.50% |
| Q4 2020 | 238.6K | $111M | +0.64% |
| Q3 2020 | 229.4K | $101M | +0.64% |
| Q2 2020 | 261.1K | $95M | +0.63% |
| Q1 2020 | 231.6K | $66M | +0.54% |
| Q4 2019 | 213.7K | $69M | +0.49% |
| Q3 2019 | 220.2K | $64M | +0.51% |
| Q2 2019 | 214.1K | $63M | +0.51% |
| Q1 2019 | 205.6K | $56M | +0.49% |
| Q4 2018 | 198.6K | $44M | +0.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of TMO.